Table 2 |
|||
|
Distant sites of first recurrence |
|||
| Sites |
ILC (n = 179; %) |
IDC (n = 2576; %) |
P |
|
|
|||
| Lungs/pleura |
9.0 |
17.6 |
0.0019 |
| CNS |
1.7 |
5.3 |
0.032 |
| Ovary |
2.2 |
0.7 |
0.0003 |
| Gastrointestinal tracta |
4.5 |
1.1 |
0.009 |
| Nodes |
15.5 |
22.0 |
0.018 |
| Bone |
34.6 |
35.5 |
NS |
| Skinb |
31.8 |
27.3 |
NS |
| Liver |
7.3 |
10.9 |
NS |
| Pituitary |
0.5 |
0.1 |
NS |
|
|
|||
|
Percentages do not add up to 100% because of multiple metastatic sites in the same patient and infrequent or unknown sites not shown. aStomach, small bowel, colon, appendix, duodenum, and peritoneum. bSoft tissue and skin. CNS, central nervous system; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; NS, not significant. |
|||
|
Arpino et al. Breast Cancer Res 2004 6:R149 |
|||
